These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 21326831)

  • 1. Lactococcus lactis as an adjuvant and delivery vehicle of antigens against pneumococcal respiratory infections.
    Medina M; Vintiñi E; Villena J; Raya R; Alvarez S
    Bioeng Bugs; 2010; 1(5):313-25. PubMed ID: 21326831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection.
    Hanniffy SB; Carter AT; Hitchin E; Wells JM
    J Infect Dis; 2007 Jan; 195(2):185-93. PubMed ID: 17191163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance of young mice to pneumococcal infection can be improved by oral vaccination with recombinant Lactococcus lactis.
    Villena J; Medina M; Racedo S; Alvarez S
    J Microbiol Immunol Infect; 2010 Feb; 43(1):1-10. PubMed ID: 20434117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral immunization with recombinant Lactococcus lactis confers protection against respiratory pneumococcal infection.
    Villena J; Medina M; Raya R; Alvarez S
    Can J Microbiol; 2008 Oct; 54(10):845-53. PubMed ID: 18923553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of lactococcal GEM-based pneumococcal vaccines.
    Audouy SA; van Selm S; van Roosmalen ML; Post E; Kanninga R; Neef J; Estevão S; Nieuwenhuis EE; Adrian PV; Leenhouts K; Hermans PW
    Vaccine; 2007 Mar; 25(13):2497-506. PubMed ID: 17081660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host immunity in the protective response to nasal immunization with a pneumococcal antigen associated to live and heat-killed Lactobacillus casei.
    Vintiñi EO; Medina MS
    BMC Immunol; 2011 Aug; 12():46. PubMed ID: 21834957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of a probiotic associated with nasal vaccination with inactivated Lactococcus lactis-PppA induces effective protection against pneumoccocal infection in young mice.
    Vintiñi E; Villena J; Alvarez S; Medina M
    Clin Exp Immunol; 2010 Mar; 159(3):351-62. PubMed ID: 20002449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cell-targeting DNA-based nasal adjuvants for protective mucosal immunity to Streptococcus pneumoniae.
    Kataoka K; Fukuyama Y; Briles DE; Miyake T; Fujihashi K
    Microbiol Immunol; 2017 Jun; 61(6):195-205. PubMed ID: 28463465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal immunization with recombinant chimeric pneumococcal protein and cell wall from immunobiotic bacteria improve resistance of infant mice to Streptococcus pneumoniae infection.
    Laiño J; Villena J; Suvorov A; Zelaya H; Ortiz Moyano R; Salva S; Alvarez S
    PLoS One; 2018; 13(11):e0206661. PubMed ID: 30395582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compound 48/80 acts as a potent mucosal adjuvant for vaccination against Streptococcus pneumoniae infection in young mice.
    Zeng L; Liu Y; Wang H; Liao P; Song Z; Gao S; Wu Y; Zhang X; Yin Y; Xu W
    Vaccine; 2015 Feb; 33(8):1008-16. PubMed ID: 25595867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal administration of Lactococcus lactis improves local and systemic immune responses against Streptococcus pneumoniae.
    Medina M; Villena J; Salva S; Vintiñi E; Langella P; Alvarez S
    Microbiol Immunol; 2008 Aug; 52(8):399-409. PubMed ID: 18667039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterologous expression of an immunogenic pneumococcal type 3 capsular polysaccharide in Lactococcus lactis.
    Gilbert C; Robinson K; Le Page RW; Wells JM
    Infect Immun; 2000 Jun; 68(6):3251-60. PubMed ID: 10816470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A.
    Oliveira ML; Arêas AP; Campos IB; Monedero V; Perez-Martínez G; Miyaji EN; Leite LC; Aires KA; Lee Ho P
    Microbes Infect; 2006 Apr; 8(4):1016-24. PubMed ID: 16549380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Combination of Recombinant Mycobacterium bovis BCG Strains Expressing Pneumococcal Proteins Induces Cellular and Humoral Immune Responses and Protects against Pneumococcal Colonization and Sepsis.
    Goulart C; Rodriguez D; Kanno AI; Converso TR; Lu YJ; Malley R; Leite LCC
    Clin Vaccine Immunol; 2017 Oct; 24(10):. PubMed ID: 28768668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced safety and immunogenicity of a pneumococcal surface antigen A mutant whole-cell inactivated pneumococcal vaccine.
    David SC; Laan Z; Minhas V; Chen AY; Davies J; Hirst TR; McColl SR; Alsharifi M; Paton JC
    Immunol Cell Biol; 2019 Sep; 97(8):726-739. PubMed ID: 31050022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal vaccine delivery of antigens tightly bound to an adjuvant particle made from food-grade bacteria.
    van Roosmalen ML; Kanninga R; El Khattabi M; Neef J; Audouy S; Bosma T; Kuipers A; Post E; Steen A; Kok J; Buist G; Kuipers OP; Robillard G; Leenhouts K
    Methods; 2006 Feb; 38(2):144-9. PubMed ID: 16414272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal immunization with Lactococcus lactis expressing the pneumococcal protective protein A induces protective immunity in mice.
    Medina M; Villena J; Vintiñi E; Hebert EM; Raya R; Alvarez S
    Infect Immun; 2008 Jun; 76(6):2696-705. PubMed ID: 18390997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status and perspectives on protein-based pneumococcal vaccines.
    Darrieux M; Goulart C; Briles D; Leite LC
    Crit Rev Microbiol; 2015 Jun; 41(2):190-200. PubMed ID: 23895377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal Immunization with the Commensal
    Shekhar S; Khan R; Schenck K; Petersen FC
    Appl Environ Microbiol; 2019 Mar; 85(6):. PubMed ID: 30683742
    [No Abstract]   [Full Text] [Related]  

  • 20. Lactococcus lactis GEM particles displaying pneumococcal antigens induce local and systemic immune responses following intranasal immunization.
    Audouy SA; van Roosmalen ML; Neef J; Kanninga R; Post E; van Deemter M; Metselaar H; van Selm S; Robillard GT; Leenhouts KJ; Hermans PW
    Vaccine; 2006 Jun; 24(26):5434-41. PubMed ID: 16757068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.